ライフサイエンスコーパス: long-term outcome

1 levels at completion of therapy may forecast long-term outcome.

2 betic macular edema (DME) is associated with long-term outcome.

3 edication adherence has a dramatic effect on long-term outcome.

4 ation with response to anti-HER2 therapy and long-term outcome.

5 a tailored protocol obtaining a satisfactory long-term outcome.

6 These children also have a very good long-term outcome.

7 with curative intent and achieve successful long-term outcome.

8 ation with response to anti-HER2 therapy and long-term outcome.

9 ty of such deficits is a strong predictor of long-term outcome.

10 erations can contribute independently to the long-term outcome.

11 ly improved, few studies have focused on its long-term outcome.

12 vide complementary prognostic information on long-term outcomes.

13 improved symptoms, and resulted in favorable long-term outcomes.

14 ed with significant differences in short- or long-term outcomes.

15 is associated with a higher risk of negative long-term outcomes.

16 lar obstruction present at baseline on these long-term outcomes.

17 yses were used to evaluate perioperative and long-term outcomes.

18 ed substantially, possibly suggesting poorer long-term outcomes.

19 personalized immunosuppression, and improved long-term outcomes.

20 surgery impact significantly the short- and long-term outcomes.

21 little is known about their association with long-term outcomes.

22 potentially placing them at risk of adverse long-term outcomes.

23 e use and hospitalizations indicate improved long-term outcomes.

24 ardiovascular abnormalities, and to describe long-term outcomes.

25 s adverse effects on insulin sensitivity and long-term outcomes.

26 SAECG that is associated with more favorable long-term outcomes.

27 R0 margin (n = 2573) in terms of short- and long-term outcomes.

28 ucing significant patient mortality and poor long-term outcomes.

29 lve gradient (AVG) are associated with worse long-term outcomes.

30 or the donor, with questions remaining about long-term outcomes.

31 mprovement and targeted treatment determines long-term outcomes.

32 l outcome prediction model performed well on long-term outcomes.

33 on is a chronic disease associated with poor long-term outcomes.

34 r LG and OG) were selected for comparison of long-term outcomes.

35 ality risk stratification as a surrogate for long-term outcomes.

36 od, despite the relevance of such effects to long-term outcomes.

37 ecovery following kidney transplantation and long-term outcomes.

38 , low rates of major complications, and good long-term outcomes.

39 resuscitation was associated with short- and long-term outcomes.

40 pearance was associated with in-hospital and long-term outcomes.

41 ory in survivors and is associated with poor long-term outcomes.

42 thin transplant centers which did not impact long-term outcomes.

43 r SS/SS to improve currently observed dismal long-term outcomes.

44 ficulties provides an opportunity to improve long-term outcomes.

45 isk, associated clinical manifestations, and long-term outcomes.

46 athogenesis, pathology, natural history, and long-term outcomes.

47 ow clinicians derive prognostic estimates of long-term outcomes.

48 OAT resumption after ICH is associated with long-term outcome, accounting for ICH location (ie, loba

49 loading, or aging and examined the effect on long-term outcome after AKI in two models: bilateral isc

50 We investigated the importance of LVEF on long-term outcome after aortic valve replacement in symp

51 S and GLS were significantly associated with long-term outcome after cardiac resynchronization therap

52 l accepted in the clinical setting, although long-term outcome after DCD lung transplantation (LTx) r

53 The authors investigated the long-term outcome after ICD implantation in a large coho

54 us is a chronic illness with great impact on long-term outcome after liver transplantation (LT).

55 aim of the present study was to analyze very long-term outcome after MV repair and replacement for de

56 is the first clinical tool to prognosticate long-term outcome after spontaneous SAH in a multidimens

57 ted to identify factors correlated with poor long-term outcome after surgery and specifically define

58 However, long-term outcomes after AVNA are uncertain, especially

59 However, the effect of surgical skill on long-term outcomes after bariatric surgery is unknown.

60 These findings suggest that long-term outcomes after bariatric surgery may be less d

61 mportant risk factor for poor short-term and long-term outcomes after CABG regardless of preoperative

62 s; however, relatively little is known about long-term outcomes after capping and abandoning leads.

63 ection negatively influences both short- and long-term outcomes after cardiothoracic transplantation.

64 Objective: To delineate perioperative and long-term outcomes after CEA in dialysis-dependent patie

65 s the single best posttreatment predictor of long-term outcomes after CIT.

66 al advances could further improve short- and long-term outcomes after coronary artery bypass grafting

67 the impact of stent oversizing on acute and long-term outcomes after drug-eluting stents implantatio

68 e performed this study to compare short- and long-term outcomes after expander, autologous (AT), and

69 graft loss, and a major barrier to improving long-term outcomes after intestinal transplantation.

70 interventions, but their relative impact on long-term outcomes after percutaneous coronary intervent

71 major challenge for the future is improving long-term outcomes after solid organ transplantation.

72 Few prospective data are available regarding long-term outcomes after surgical closure of a ventricul

73 , and the prognostic factors associated with long-term outcomes after surgical resection remain poorl

74 ervational studies have attempted to address long-term outcomes after surgical versus percutaneous re

75 Growth retardation is a major adverse long-term outcome among BHFS patients with approximately

76 ion and its association with in-hospital and long-term outcomes among patients with decompensated HFp

77 Y as they age are urgently needed to improve long-term outcomes among PHIVY.

78 visiting by nurses and the impact of this on long term outcomes and related cost-effectiveness of hom

79 ith reduced fractional flow reserve improves long-term outcome and is economically attractive compare

80 egistry was set up in 27 centers to evaluate long-term outcome and outcome correlates in 2 distinct p

81 further intervention, thereby improving the long-term outcome and preventing T2D.

82 We assess long-term outcome and prognosis factors for vascular com

83 igand 2 (CCL2) as a noninvasive predictor of long-term outcomes and compare it with 6-month urinary C

84 encouraging, but data are lacking regarding long-term outcomes and comparisons with matched HIV- pat

85 ese 10-year data help to more clearly define long-term outcomes and demonstrate outstanding reduction

86 We aimed to define long-term outcomes and explore risk stratification in pa

87 care continuum provides greater insight into long-term outcomes and exposes disparities not evident w

88 Long-term outcomes and more definitive quality-of-life s

89 More information about long-term outcomes and patient and societal preferences

90 equired to investigate effect of delirium on long-term outcomes and possible preventive and treatment

91 is not leading to novel therapies improving long-term outcomes and safety, and hence important unmet

92 es, offer patients realistic expectations of long-term outcomes, and support decision making.

93 Long-term outcomes are associated with recovery status a

94 As long-term outcomes are best predicted by the CRM status,

95 ents with aortic root aneurysms, comparative long-term outcomes are lacking.

96 n 3 or more sentinel nodes are obtained, but long-term outcomes are lacking.

97 of use of human donor milk on short-term and long-term outcomes are necessary.

98 ss in patients with subclinical disease, but long-term outcomes are not known.

99 but implications of change in insurance for long-term outcomes are unclear.

100 For EGS patients with CLD, long-term outcomes are unknown and risk stratification m

101 tial thickness corneal grafts have favorable long-term outcome as a patch for GDD tubes with low rate

102 , this approach has been limited in terms of long-term outcome as well as economic and technical burd

103 ry-artery bypass grafting (CABG) may improve long-term outcomes as compared with the use of a single

104 nsplantation, with comparable short-term and long-term outcomes as organs from lean donors.

105 id strategy and is associated with excellent long-term outcome; as early (<6 months) recurrence refle

106 nical trial to prospectively investigate the long-term outcomes associated with the timing of RRT ini

107 This study evaluated the long-term outcome at 11-13 years of age of children who

108 We report the long-term outcome based on the largest multicentre cohor

109 n are more closely associated with important long-term outcomes, but often depend upon invasive and c

110 y valve has demonstrated good short-term and long-term outcomes, but there are no published studies f

111 Excellent long-term outcome can be achieved in expert centers.

112 The results suggest that good long-term outcomes can be achieved using aflibercept for

113 Little information is available on long-term outcomes, comorbidities, and treatment efficac

114 ithout rituximab or splenectomy, can achieve long-term outcomes comparable to ABO-compatible transpla

115 Group SLT had similar postoperative and long-term outcomes compared with group PLT (starting fro

116 reatment as usual in depression has superior long-term outcomes compared with treatment as usual only

117 ructive coronary artery disease, and similar long-term outcomes, compared with men.

118 art transplantation is associated with worse long-term outcomes, compounding disparities in post-tran

119 This study was performed to show long-term outcomes concerning globe preservation in uvea

120 No long-term outcome data are yet available for the leadles

121 Long-term outcome data from nonenrolled eligible patient

122 were extended with additional treatment and long-term outcome data.

123 Long-term outcomes did not differ between groups (all P

124 in Hispanics than in non-Hispanics, whether long-term outcomes differ between these groups is unclea

125 esser molecular responses and have excellent long-term outcomes even without SCT.

126 iate attention to edge effects, may optimize long-term outcomes, even in drug-eluting stents implanta

127 ) is a possible option, but few data on very-long-term outcomes exist.

128 Preliminary studies suggest better long-term outcomes following cognitive-behavioral therap

129 The long-term outcome for children that have received treatm

130 Long-term outcomes for adults who underwent EA/TEF repai

131 We aimed to report long-term outcomes for patients undergoing per-oral endo

132 of a comprehensive risk-reduction program on long-term outcomes for patients with PAD.

133 Infected children with a better long-term outcome had higher numbers of B cells at birth

134 However, the improvement in long-term outcomes has been modest.

135 inically silent and remained undetected, but long-term outcomes have not been determined.

136 arly experience with TAR has been promising, long-term outcomes have not been reported.

137 However, long-term outcomes have not improved, and nearly half of

138 This study compared the long term outcomes in patients with unprotected left mai

139 Purpose To assess the long-term outcome in 108 consecutive patients treated wi

140 We studied long-term outcome in 474 consecutive HCM patients betwee

141 Long-term outcome in childhood was measured on the basis

142 lete response could be an early indicator of long-term outcome in early-stage HER2-positive breast ca

143 s and quantifies PR and CR as surrogates for long-term outcome in MGN.

144 ently associated with a more benign clinical long-term outcome in multivariate logistic regression an

145 vWF is an independent predictor of long-term outcome in patients with HFpEF, which is in li

146 ith de novo transplants and portend negative long-term outcome in patients with renal transplants.

147 using 2 techniques that have shown favorable long-term outcome in previous randomized studies: Lichte

148 lled "treatment response"--strongly predicts long-term outcome in primary biliary cholangitis (PBC).

149 Identifying predictors of long-term outcome in pulmonary arterial hypertension is

150 hese noncardiac complications may affect the long-term outcome in these patients and what modifiable

151 hort study determining the effectiveness and long-term outcome in this group of patients.

152 We aimed to investigate the long-term outcomes in a cohort of participants who previ

153 This study sought to examine long-term outcomes in a contemporary group of patients w

154 umor subtype and response to chemotherapy on long-term outcomes in a node-positive cohort receiving n

155 L evaluations and their prognostic value for long-term outcomes in breast cancer (BC).

156 at 6-month outcomes may be useful to predict long-term outcomes in CAF procedures with or without add

157 However, the effect of delivery by CS on long-term outcomes in children is unclear.

158 In our experience, both short- and long-term outcomes in DCD lung recipients are comparable

159 We aimed to investigate long-term outcomes in individuals from a primary care po

160 worldwide, but scant data are available for long-term outcomes in individuals outside North America

161 Our aim is to evaluate long-term outcomes in liver transplant recipients transp

162 ieve R0 status are associated with different long-term outcomes in pancreatic cancer patients.

163 To evaluate long-term outcomes in patients who underwent PBI for the

164 ions between markers of disease severity and long-term outcomes in patients with inoperable CTEPH or

165 Biomarkers to estimate long-term outcomes in patients with multiple sclerosis (

166 associations between efficacy parameters and long-term outcomes in patients with pulmonary arterial h

167 impact of baseline pulmonary hypertension on long-term outcomes in patients with significant primary

168 The RL and LL grafts provide comparable long-term outcomes in properly selected donor-recipient

169 trials are needed in current era to evaluate long-term outcomes in routine use of EPD, and meanwhile,

170 st that SALV can offer acceptable short- and long-term outcomes in selected patients at experienced c

171 uate and identify risk factors for early and long-term outcomes in such patients.

172 The prediction of long-term outcomes in surviving infants born very preter

173 lly designed prognostic modeling studies for long-term outcomes in surviving VPT/VLBW children.

174 The aim of our study was to compare long-term outcomes in terms of major adverse cardiovascu

175 e (IOP) after trabeculectomy and to describe long-term outcomes in these eyes.

176 of baseline TR may be an important marker of long-term outcomes in this population.

177 hospitalization, particularly with regard to long-term outcomes including readmission and mortality.

178 We then evaluated rates of long-term outcomes, including 30-day readmission, 30-day

179 We find that long-term outcomes, including community collapse, divers

180 The relationship between IMA failure and long-term outcomes, including death, myocardial infarcti

181 n of AKI was also a significant predictor of long-term outcomes irrespective of severity.

182 ollowing surgery is common and its impact on long-term outcome is poorly understood.

183 However, the long-term outcome is unknown.

184 frequency and predictors of IMA failure and long-term outcomes is lacking.

185 A randomized trial with long-term outcomes is needed to definitively compare the

186 pressure and proteinuria, yet the impact on long-term outcomes is uncertain in chronic kidney diseas

187 hoblastic leukaemia, although its effects on long-term outcomes is unknown.

188 tation, and size of largest lesion predicted long-term outcome, likely pointing to a lower burden of

189 ploratory decisions in an attempt to improve long-term outcomes may diminish in favor of more repetit

190 Information about long-term outcomes may influence physician and patient d

191 nical value of this marker as a predictor of long-term outcome merit further evaluation.

192 pplied in ordinary wards was effective, with long-term outcomes not different from those reported for

193 We determined the long-term outcome of 265 consecutive chronic hepatitis B

194 Methods Long-term outcome of 618 survivors from consecutive Ewin

195 To analyze long-term outcome of a randomized clinical trial compari

196 We sought to determine the long-term outcome of CA of VT in patients with cardiac s

197 Comprehensive long-term outcome of eligible nonenrolled patients has n

198 im of this study was to analyze the clinical long-term outcome of hepatitis delta in relation to diff

199 the kynurenine (kyn) pathway to predict the long-term outcome of human kidney transplantation.

200 The long-term outcome of intestinal transplantations is stil

201 Limited data are available on the long-term outcome of IVF patients.

202 Long-term outcome of mothers and children is needed and

203 The aim of this study was to assess the long-term outcome of patients with AA nephropathy (AAN)

204 We examined the long-term outcome of patients with newly diagnosed APL t

205 The long-term outcome of single-ventricle management in thes

206 have a significant impact on medium-term to long-term outcome of these patients.

207 revalence of up to 5% and is the most severe long-term outcome of this common disorder.

208 ce with the technique is needed to determine long-term outcome of this procedure.

209 The aim of the study was to compare long-term outcomes of 2 groups of morbidly obese patient

210 rt-term organ dysfunction could also improve long-term outcomes of 28-day survivors of septic shock.

211 last decades, in our case report we describe long-term outcomes of a devastating complication of opht

212 We evaluated long-term outcomes of a large cohort of patients with BD

213 This study examined the long-term outcomes of aortic valve-sparing operations in

214 Little is known about the long-term outcomes of bariatric surgery for severe adole

215 Therefore, we investigated the negative long-term outcomes of cancer-bereaved sons' and daughter

216 rds long-term conditions means understanding long-term outcomes of cardiovascular disease is increasi

217 -matched observational studies comparing the long-term outcomes of coronary artery bypass grafting wi

218 (4) what are the long-term outcomes of CT-FFR-guided treatment and how do

219 To report the indications and long-term outcomes of deep anterior lamellar keratoplast

220 Juvenile Project, a longitudinal US study of long-term outcomes of delinquent youth after detention,

221 We sought to determine the long-term outcomes of endocardial and adjuvant epicardia

222 Despite this, the long-term outcomes of HCV+ liver transplant recipients t

223 We investigated long-term outcomes of IBT on the population.

224 There is a paucity of studies examining long-term outcomes of immediate loading of dental implan

225 This study aims to evaluate long-term outcomes of immediate loading of postextractio

226 l, natural experiment investigation into the long-term outcomes of individuals who spent from soon af

227 o assess the incidence, cumulative rate, and long-term outcomes of infectious and noninfectious endop

228 The impact of pre-donation obesity on long-term outcomes of living kidney donors remains contr

229 To compare the safety and long-term outcomes of MAG vs LITA+SVG among overall and

230 e aim of this study was to assess short- and long-term outcomes of malignant biliary obstruction (MBO

231 howed strong prognostic performance with the long-term outcomes of metastasis-free and overall surviv

232 y syndromes or stable angina and to evaluate long-term outcomes of nonenrolled eligible patients trea

233 To investigate the long-term outcomes of ocular surface stem cell allograft

234 The long-term outcomes of off-pump coronary artery bypass gr

235 The purpose of this study is to report the long-term outcomes of partial thickness corneal grafts t

236 race and low socioeconomic status (SES) with long-term outcomes of patients after acute myocardial in

237 We investigated incidence and long-term outcomes of patients diagnosed with these clas

238 To analyze the characteristics and long-term outcomes of patients that underwent pediatric

239 Long-term outcomes of patients treated with venoarterial

240 ty, and initial clinical presentation to the long-term outcomes of patients undergoing coronary angio

241 We sought to compare the long-term outcomes of patients undergoing the Ross proce

242 However, the long-term outcomes of patients who undergo incident hemo

243 Very few reports of long-term outcomes of patients who underwent the Ross pr

244 multicentre ChroPac trial to investigate the long-term outcomes of patients with chronic pancreatitis

245 albumin-bilirubin (ALBI) grade to assess the long-term outcomes of patients with early-stage hepatoce

246 ing new therapy to substantially improve the long-term outcomes of PBC patients, but at its current a

247 5766 participants in a prospective study of long-term outcomes of pediatric patients with IBD (NCT00

248 affolds (BVS) offer the potential to improve long-term outcomes of percutaneous coronary intervention

249 affolds (BVS) offer the potential to improve long-term outcomes of percutaneous coronary intervention

250 We simulated a virtual trial comparing long-term outcomes of pre-LT versus post-LT HCV treatmen

251 imited data on harms, and sparse evidence on long-term outcomes of screening and treatment among chil

252 To evaluate the long-term outcomes of second Ahmed glaucoma valve (AGV)

253 acial allograft donor surgery experience and long-term outcomes of the concomitantly recovered solid

254 To assess the long-term outcomes of the various recommended SBP levels

255 Understanding the long-term outcomes of these conditions may inform patien

256 This review aims to: 1) assess the long-term outcomes of untreated buccal gingival recessio

257 Long-term outcomes of viability imaging-assisted managem

258 compare with other regimens and evaluate the long-term outcome, particularly on fertility.

259 Considering all published data reporting long-term outcomes pooled proportion meta-analysis indic

260 dentification of early factors predictive of long-term outcome post-LT in HCV-negative recipients.

261 quality of life and unfavourable effects on long-term outcomes, raising the possibility of a future

262 systems of training parameters, focusing on long-term outcomes rather than short-term outcomes, and

263 ation for BITA utilization and its effect on long-term outcome remains uncertain.

264 Although long-term outcome remains unclear, the initial change in

265 stational age may be possible, its effect on long-term outcomes requires further studies.

266 prognostic indicators of favorable and poor long-term outcome, respectively, in children with steroi

267 sed or treated at our institution to analyze long-term outcome, response to treatment, and incidence

268 Yet, population-based, long-term outcome studies are few.

269 Ultimately, prospective, long-term outcome studies focusing on multiple aspects o

270 sessed at 6- and 12-month follow-up (ARDSNet Long-Term Outcome Study) and 36-, 48-, and 60-month foll

271 uld assess the effects of such a strategy on long-term outcomes such as bowel damage, surgeries, hosp

272 Long-term outcomes, such as readmissions and delayed spl

273 include assessments of programme structure; long-term outcomes, such as survival, quality-adjusted l

274 nd MRI criteria during the first 2 years had long-term outcomes that were no different from those of

275 ffolds have the potential to further improve long-term outcomes, they have not yet achieved results e

276 ssed parents has been widely replicated, the long-term outcome through their full age of risk is less

277 OPCAB is associated with similar long-term outcomes to CABG performed on CPB in our insti

278 The long-term outcome was excellent, with survival of 87% at

279 Long-term outcome was studied histologically at day 60.

280 Long-term outcome was studied with respect to heart func

281 The long-term outcome was worse in ICU survivors of sepsis w

282 Association between efficacy parameters and long-term outcomes was assessed using Kaplan-Meier analy

283 circulating concentrations of PLP influences long-term outcome.We compared vitamin B-6 intake and cir

284 Long-term outcomes were analyzed using random effects re

285 l characteristics and in-hospital as well as long-term outcomes were assessed.

286 Post SLT, short and long-term outcomes were comparable with PLT.

287 Short-term (within 30 days) and long-term outcomes were evaluated.

288 isual impairment in the short term, although long-term outcomes were unavailable.

289 Hospital survivors have good long-term outcomes, which demonstrate the beneficial eff

290 ge Liver Disease score was not predictive of long-term outcome, while Lille score (P = 0.02) and alco

291 To correlate this long-term outcome with differences in the early injury p

292 Long-term outcome with regard to tachycardia recurrence

293 In conclusion, noninfectious MCGN has a poor long-term outcome with severe infections as the main cau

294 This meta-analysis aimed to compare the long-term outcomes with both devices.

295 n coronary artery disease (CAD) had improved long-term outcomes with coronary artery bypass graft (CA

296 The long-term outcomes with PPK for HSV keratitis in childre

297 r coronary artery bypass grafting (CABG), on long-term outcomes with respect to LVEF and number of di

298 d Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Typ

299 [Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide], -24%).

300 help determine which patients have favorable long-term outcomes with this therapy.